One of the long standing admonitions is that the last place one gives a new drug is to a pregnant woman. The Thalidomide disaster of half a century ago demonstrated that extra care was needed when administering drugs to pregnant women. The results then were more than 10,000 children born with a range of severe deformities as well as thousands of miscarriages. Roughly 40% of these children died at birth or shortly afterward. Are these COVID drug therapies safe during pregnancy?
We have been told ad nauseum that the vaccines are “safe and effective.” In view of the limited testing period before introduction of the mRNA therapies, how was it determined that they were okay for pregnant women? Pregnancy is a nine-month process. Why were doctors telling women that getting jabbed was okay? What data was being used to push these drugs on pregnant women?
In Israel, a country with an early high vaccination rate, the Health Ministry specifically recommended against being jabbed during the first trimester. This is due to the sensitive developmental stages of the fetus and the increased possibility of a miscarriage.
The New England Journal of Medicine has a study called “Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons.” It purports to study the effects that the COVID vaccine has on pregnancies, including miscarriages, stillbirths, anomalies, and live births. It was posted in June 2021.
Of specific interest is the data on miscarriages. Let’s be reminded that the technical definition of a miscarriage is the spontaneous loss of a pregnancy before the 20th week. Depending on which medical publication one looks at, the rate of miscarriages in this country ranges from 10% to 25%.
What did the study find?
“Among 827 participants who had a completed pregnancy, the pregnancy resulted in a live birth in 712 (86.1%), in a spontaneous abortion in 104 (12.6%), in stillbirth in 1 (0.1%), and in other outcomes (induced abortion and ectopic pregnancy) in 10 (1.2%). A total of 96 of 104 spontaneous abortions (92.3%) occurred before 13 weeks of gestation (Table 4), and 700 of 712 pregnancies that resulted in a live birth (98.3%) were among persons who received their first eligible vaccine dose in the third trimester.”
Let’s keep in mind the dates here. The study, which is ongoing, released preliminary findings in June. At this point the vast majority of completed pregnancies would be those which were well underway before mass vaccination kicked in. In fact assuming a uniform distribution of pregnancies with a first trimester jab, there were probably still at least 800 pregnancies underway that were within the technical period where a miscarriage could occur.
The percentages given in the published document are misleading at best. It almost appears as if the authors were attempting to poohpooh the idea that anything untoward was occurring with pregnant women. This may be because of anecdotal reports about significantly higher miscarriage rates. There have also been reports of significantly higher occurrences of heavy bleeding during menstrual cycles. This may also indicate a potential miscarriage during the very early stages of a pregnancy.
These numbers will change as more pregnancies complete either with a live birth or otherwise. Is the rate much higher than normal? There are respected researchers who believe this to be true.
New Zealand researcher Dr. Aleisha Brock and Dr. Simon Thornley, a senior lecturer in the University of Auckland’s Section of Epidemiology and Biostatistics, calculated the incidence of miscarriage in women vaccinated before 20 weeks gestation was actually 82-91% in a paper published in Science, Public Health Policy, and the Law in November 2021. “We question the conclusions of the Shimabukuro et al. study to support the use of the mRNA vaccine in early pregnancy, which has now been hastily incorporated into many international guidelines for vaccine use, including in New Zealand,” the researchers said.
“The assumption that exposure in the third trimester cohort is representative of the effect of exposure throughout pregnancy is questionable and ignores past experience with drugs such as thalidomide. Evidence of safety of the product when used in the first and second trimesters cannot be established until these cohorts have been followed to at least the perinatal period or long-term safety determined for any of the babies born to mothers inoculated during pregnancy,” they added.
Note that, as with thalidomide, we also need to look at birth and post birth events. Babies sometimes die. Different countries have different ways of characterizing such data. However, regardless of the method, when the rate of death spikes well above the standard baseline, it is cause for concern.
Scotland has experienced such a spike. Now, infant deaths can vary widely from month to month. However, Scotland’s increase is beyond the pale.
Let’s keep in mind that pregnant women were not at the front of the line when it came to vaccination. So, September was probably the first month when significant numbers of women who were jabbed during their first trimester would give birth. What happened to the death rate of newborns?
Scotland’s newborn death rate per 1,000 births prior to the COVID therapies was a little over 2. In September it spiked to almost 5. Are the mRNA therapies to blame? That is unknown. Is a wide inquiry into the causes of this spike needed? Absolutely. Autopsies are urgently needed to help ascertain the causes. This leads to another elephant in the room. Why were no autopsies done on people in this country who died after being jabbed? What were they afraid they would find?